| Today, Mon, Nov 9, 2009 | | • | UPDATE - Dendreon Q3 loss wider than expected on higher expenses
at Reuters (Mon 3:01pm)
| | • | InPlay: Dendreon misses by $0.21, beats on revs
Briefing.com (Mon 2:27pm)
| | • | DENDREON CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon 2:21pm)
| | • | Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
Wall Street Transcript (Mon 1:50pm)
| | • | 7 Reasons Not to Worry This Week
at Motley Fool (Mon 10:01am)
| | Fri, Nov 6, 2009 | | • | Cramer's 8 Picks for Cancer's Cure
at CNBC (Fri, Nov 6)
| | • | Cramer's 'Mad Money' Follow-Up: Nov. 6
at TheStreet.com (Fri, Nov 6)
| | • | Buzz of the Street: Gold 1100?
at Minyanville.com (Fri, Nov 6)
| | • | 5 Cold Stocks Heating Up
at Motley Fool (Fri, Nov 6)
| | • | Biotech Stock Mailbag: Poniard Predictions
at TheStreet.com (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | 2 Takeover Targets in the Pharma Market
at CNBC (Thu, Nov 5)
| | • | [video] Battling Cancer with Biotech
at CNBC (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | • | Big Pharma Again Taking Shot At Vaccines
Investor's Business Daily (Tue, Nov 3)
| | • | DENDREON CORP Files SEC form 8-K, Other Events
EDGAR Online (Tue, Nov 3)
| | • | This Just In: Upgrades and Downgrades
at Motley Fool (Tue, Nov 3)
| | • | Dendreon's Provenge Looks Likely to Be Approved in Mid-2010
at Seeking Alpha (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Dendreon submits Provenge to FDA
at bizjournals.com (Mon, Nov 2)
| | • | Biopharma's Bustin' Out All Over
at CNBC (Mon, Nov 2)
| | • | Dendreon completes FDA submission for cancer drug
AP (Mon, Nov 2)
| | • | Amylin Makes Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
|
Add DNDN News to My Yahoo!:
 
| |
|
2.03% Nasdaq 
Headlines
